{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:45:00Z","timestamp":1794336300573,"version":"4.9.0"},"reference-count":395,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.atherosclerosis.2025.120424","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:59:40Z","timestamp":1752569980000},"page":"120424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Unlocking the secrets: Adipose tissue dysfunction and atherosclerosis-mechanisms and innovative therapeutic approaches"],"prefix":"10.1016","volume":"408","author":[{"given":"Dana Bou","family":"Matar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Affan","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3736-5989","authenticated-orcid":false,"given":"Hatouf","family":"Sukkarieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid Khaled","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-5454","authenticated-orcid":false,"given":"Ahmad","family":"Aljada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.120424_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-245-8_1","article-title":"Overview of adipose tissue and its role in obesity and metabolic disorders","volume":"456","author":"Fr\u00fchbeck","year":"2008","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14712\/23362936.2015.49","article-title":"Adipose tissue as an endocrine organ: an update on pro-inflammatory and anti-inflammatory microenvironment","volume":"116","author":"Smitka","year":"2015","journal-title":"Prague Med Rep"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib3","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1098\/rsob.200291","article-title":"Adipose tissue in health and disease","volume":"10","author":"Harvey","year":"2020","journal-title":"Open Biology"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib5","article-title":"A palette of adipose tissue: multiple functionality and extraordinary plasticity","volume":"4","author":"Pauli","year":"2021","journal-title":"Trend Anat Physiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tice.2016.08.001","article-title":"Mandarim-de-Lacerda, CA, Brown adipose tissue: updates in cellular and molecular biology","volume":"48","author":"Bargut","year":"2016","journal-title":"Tissue Cell"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120424_bib7","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/en.2018-00371","article-title":"Multifaceted roles of beige fat in energy homeostasis beyond UCP1","volume":"159","author":"Sponton","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib8","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1530\/EJE-13-0945","article-title":"White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ","volume":"170","author":"Giordano","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib9","first-page":"3","article-title":"Potential role of perivascular adipose tissue in modulating atherosclerosis","volume":"vol. 134","author":"Ahmadieh","year":"2020"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12933-018-0777-x","article-title":"Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword","volume":"17","author":"Qi","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1570161112666140423220628","article-title":"Perivascular adipose tissue, inflammation and vascular dysfunction in obesity","volume":"12","author":"van de Voorde","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14797\/mdcj-13-1-20","article-title":"Epicardial fat in the maintenance of cardiovascular health","volume":"13","author":"Wu","year":"2017","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/biology11030355","article-title":"Role of epicardial adipose tissue in cardiovascular diseases: a review","volume":"11","author":"Konwerski","year":"2022","journal-title":"Biology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1381612824666180110102125","article-title":"The role of inflammation in epicardial adipose tissue in heart diseases","volume":"24","author":"Matloch","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.33549\/physiolres.933036","article-title":"The role of epicardial adipose tissue in heart disease","volume":"65","author":"Matloch","year":"2016","journal-title":"Physiol Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib16","doi-asserted-by":"crossref","first-page":"1167952","DOI":"10.3389\/fendo.2023.1167952","article-title":"The role of epicardial adipose tissue dysfunction in cardiovascular diseases: an overview of pathophysiology, evaluation, and management","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib17","article-title":"Epicardial adipose tissue assessed by computed tomography and echocardiography are associated with adverse cardiovascular outcomes: a systematic review and meta-analysis","volume":"16","author":"Chong","year":"2023","journal-title":"Circ Cardiovasc Imag"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120424_bib18","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1210\/jc.2003-030698","article-title":"Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk","volume":"88","author":"Iacobellis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib19","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190770","article-title":"Novel imaging biomarkers: epicardial adipose tissue evaluation","volume":"93","author":"Monti","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006379","article-title":"Association of epicardial adipose tissue and high\u2010risk plaque characteristics: a systematic review and meta\u2010analysis","volume":"6","author":"Nerlekar","year":"2017","journal-title":"J Am Heart Assoc: Cardiovasc Cerebrovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2013.00052","article-title":"Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies","volume":"4","author":"McArdle","year":"2013","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib22","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.3390\/ijms20194924","article-title":"The role of adipose tissue mitochondria: regulation of mitochondrial function for the treatment of metabolic diseases","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib23","article-title":"White adipose tissue mitochondrial metabolism in health and in obesity","volume":"21","author":"Heinonen","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126681","article-title":"Adipocyte mitochondria: deciphering energetic functions across fat depots in obesity and type 2 diabetes","volume":"25","author":"Das","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120424_bib25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cmet.2012.10.016","article-title":"Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance","volume":"16","author":"Vernochet","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib26","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1096\/fj.14-253971","article-title":"Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications","volume":"28","author":"Vernochet","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib27","doi-asserted-by":"crossref","first-page":"30658","DOI":"10.1074\/jbc.M800510200","article-title":"Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells","volume":"283","author":"Shi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S0029665107005277","article-title":"High-fat diet, muscular lipotoxicity and insulin resistance","volume":"66","author":"Schrauwen","year":"2007","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/15733998113099990074","article-title":"Emerging role of JNK in insulin resistance","volume":"9","author":"Li","year":"2013","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120424_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.coph.2009.07.004","article-title":"Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation","volume":"9","author":"Tanti","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib31","article-title":"PINK1-Parkin-Mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/biomedicines9030258","article-title":"From mitochondria to atherosclerosis: the inflammation path","volume":"9","author":"Su\u00e1rez-Rivero","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/dna.2018.4552","article-title":"Mitochondrial dysfunction in atherosclerosis","volume":"38","author":"Peng","year":"2019","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.freeradbiomed.2016.06.011","article-title":"The role of mitochondrial DNA damage in the development of atherosclerosis","volume":"100","author":"Yu","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCRESAHA.119.315644","article-title":"Age-associated mitochondrial dysfunction accelerates atherogenesis","volume":"126","author":"Tyrrell","year":"2019","journal-title":"Circulation research"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116587","article-title":"Effects of mitochondrial dysfunction on cellular function: role in atherosclerosis","volume":"174","author":"Xu","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5758\/vsi.230116","article-title":"Role of PTEN-induced protein kinase 1 as a mitochondrial dysfunction regulator in cardiovascular disease pathogenesis","volume":"40","author":"Gwon","year":"2024","journal-title":"Vascul Special Int"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120424_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5551\/jat.3939","article-title":"Adipose tissue, inflammation and atherosclerosis","volume":"17","author":"Gustafson","year":"2010","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib39","doi-asserted-by":"crossref","first-page":"139239","DOI":"10.1155\/2013\/139239","article-title":"Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines","volume":"2013","author":"Makki","year":"2013","journal-title":"ISRN Inflammat"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.pathol.2.010506.091859","article-title":"Endocrine functions of adipose tissue","volume":"2","author":"Waki","year":"2007","journal-title":"Ann Rev Pathol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib42","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/joim.12803","article-title":"Inflammation of brown\/beige adipose tissues in obesity and metabolic disease","volume":"284","author":"Villarroya","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.numecd.2016.12.005","article-title":"Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: gaps and open questions","volume":"27","author":"Ruscica","year":"2017","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","article-title":"Adipokines, adiposity, and atherosclerosis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1235953","article-title":"Adipokines in atherosclerosis: unraveling complex roles","volume":"10","author":"Luo","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2734321","article-title":"Exploring the relationship of perivascular adipose tissue inflammation and the development of vascular pathologies","volume":"2022","author":"Rami","year":"2022","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cvr\/cvac131","article-title":"Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans","volume":"119","author":"Ying","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature11132","article-title":"PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells","volume":"486","author":"Cipolletta","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib50","article-title":"Sodium-glucose cotransporter-2 (SGLT2) inhibitors and cardiovascular outcomes: a review of literature","volume":"16","author":"Mani","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12929-021-00720-y","article-title":"PPARgamma activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity","volume":"28","author":"Chen","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib52","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1161\/ATVBAHA.114.303030","article-title":"Proinflammatory phenotype of perivascular adipocytes","volume":"34","author":"Omar","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fphys.2018.00003","article-title":"Roles of perivascular adipose tissue in the pathogenesis of atherosclerosis","volume":"9","author":"Tanaka","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105890","article-title":"The physiologic and physiopathologic roles of perivascular adipose tissue and its interactions with blood vessels and the renin-angiotensin system","author":"Balakumar","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmet.2017.12.014","article-title":"Distinct adipocyte progenitor cells are associated with regional phenotypes of perivascular aortic fat in mice","volume":"9","author":"Tran","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib56","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.112.104489","article-title":"Loss of perivascular adipose tissue on peroxisome proliferator\u2013activated receptor-\u03b3 deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis","volume":"126","author":"Chang","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120424_bib57","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1139\/y2012-053","article-title":"Adipokines and the cardiovascular system: mechanisms mediating health and disease","volume":"90","author":"Northcott","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120424_bib58","doi-asserted-by":"crossref","first-page":"H2148","DOI":"10.1152\/ajpheart.00907.2011","article-title":"Inflammation and metabolic dysfunction: links to cardiovascular diseases","volume":"302","author":"Taube","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1188844","article-title":"Adipose tissue expansion in obesity, health, and disease","volume":"11","author":"White","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111315","article-title":"Adipose tissue and insulin resistance in obese","volume":"137","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib61","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1515\/CCLM.2011.697","article-title":"New insights into adipose tissue dysfunction in insulin resistance","volume":"49","author":"Mlinar","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib62","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib63","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/joim.12803","article-title":"Inflammation of brown\/beige adipose tissues in obesity and metabolic disease","volume":"284","author":"Villarroya","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cvr\/cvac131","article-title":"Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans","volume":"119","author":"Ying","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib65","doi-asserted-by":"crossref","first-page":"1235953","DOI":"10.3389\/fcvm.2023.1235953","article-title":"Adipokines in atherosclerosis: unraveling complex roles","volume":"10","author":"Luo","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib66","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","article-title":"Adipokines, adiposity, and atherosclerosis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120424_bib67","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1253\/circj.CJ-17-0458","article-title":"Role of adipokines in cardiovascular disease","volume":"81","author":"Lau","year":"2017","journal-title":"Circ J : Off J Japanese Circulat Soc"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib68","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/cvr\/cvx111","article-title":"The interplay between adipose tissue and the cardiovascular system: is fat always bad?","volume":"113","author":"Akoumianakis","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120424_bib69","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, adipose tissue and vascular dysfunction","volume":"128","author":"Koenen","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","article-title":"The role of adipose tissue in cardiovascular health and disease","volume":"16","author":"Oikonomou","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fphys.2018.00070","article-title":"PVAT and its relation to Brown, beige, and white adipose tissue in development and function","volume":"9","author":"Hildebrand","year":"2018","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/j.2040-4603.2018.tb00004.x","article-title":"Role of perivascular adipose tissue in health and disease","volume":"8","author":"Fern\u00e1ndez-Alfonso","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib73","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tem.2015.04.003","article-title":"Regional differences in perivascular adipose tissue impacting vascular homeostasis","volume":"26","author":"Gil-Ortega","year":"2015","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib74","article-title":"PVAT: an important guardian of the cardiovascular system","author":"Liang","year":"2020","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bph.12479","article-title":"Perivascular fat, AMP\u2010activated protein kinase and vascular diseases","volume":"171","author":"Almabrouk","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2015.09.012","article-title":"Human perivascular adipose tissue dysfunction as a cause of vascular disease: focus on vascular tone and wall remodeling","volume":"766","author":"Ozen","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120424_bib77","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1042\/CS20190227","article-title":"Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease","volume":"134","author":"Rafeh","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib78","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/heartjnl-2017-312324","article-title":"Perivascular adipose tissue and coronary atherosclerosis","volume":"104","author":"Mancio","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib79","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1111\/bph.13705","article-title":"Perivascular adipose tissue inflammation in vascular disease","volume":"174","author":"Nosalski","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib80","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1111\/bph.15634","article-title":"Perivascular fat imaging by computed tomography (CT): a virtual guide","volume":"178","author":"Kotanidis","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib81","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcct.2019.03.006","article-title":"State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue?","volume":"13","author":"Antoniades","year":"2019","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib82","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-019-0817-3","article-title":"Perivascular adipose tissue and coronary atherosclerosis: from biology to imaging phenotyping","volume":"21","author":"Lin","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib83","doi-asserted-by":"crossref","first-page":"17765","DOI":"10.1073\/pnas.1902007116","article-title":"Site-specific impairment of perivascular adipose tissue on advanced atherosclerotic plaques using multimodal nonlinear optical imaging","volume":"116","author":"Kim","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2024.159484","article-title":"Imaging of perivascular adipose tissue in cardiometabolic diseases by Raman spectroscopy: Towards single-cell analysis, Biochimica et biophysica acta","author":"Stanek","year":"2024","journal-title":"Mol Cell Biol Lip"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib85","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/heartjnl-2017-312324","article-title":"Perivascular adipose tissue and coronary atherosclerosis","volume":"104","author":"Mancio","year":"2018","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib87","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/ATVBAHA.120.315779","article-title":"Macrophage immunometabolism in perivascular adipose tissue","volume":"41","author":"Shi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib88","first-page":"637","article-title":"The macrophage switch in obesity development","volume":"6","author":"Castoldi","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib89","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cvr\/cvx108","article-title":"The role of infiltrating immune cells in dysfunctional adipose tissue","volume":"113","author":"Guzik","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120424_bib91","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbalip.2017.05.012","article-title":"Haematopoietic TLR4 deletion attenuates perivascular brown adipose tissue inflammation in atherosclerotic mice, Biochimica et biophysica acta","volume":"1862","author":"Liu","year":"2017","journal-title":"Mol Cell Biol Lip"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib92","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1113\/EP086818","article-title":"Aortic dysfunction in metabolic syndrome mediated by perivascular adipose tissue TNF\u03b1\u2010 and NOX2\u2010dependent pathway","volume":"103","author":"DeVallance","year":"2018","journal-title":"Exp Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.crvi.2017.01.001","article-title":"[Inflammation in the perivascular adipose tissue and atherosclerosis]","volume":"340","author":"Hamlat-Khennaf","year":"2017","journal-title":"C R Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib94","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1096\/fasebj.30.1_supplement.1282.7","article-title":"Perivascular adipose tissue derived TNF \u03b1 neutralization recovers aortic function in metabolic syndrome","volume":"30","author":"DeVallance","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-94-024-1170-6_4","article-title":"Adipose tissue-resident regulatory T cells","volume":"1011","author":"Zhu","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120424_bib96","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib97","first-page":"1","article-title":"Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?","volume":"15","author":"Maslov","year":"2018","journal-title":"J Clinic Translat Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib98","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2337\/db14-1011","article-title":"Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue","volume":"64","author":"Antonopoulos","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib99","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3390\/biom5021143","article-title":"Hypoxia, oxidative stress and fat","volume":"5","author":"Netzer","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib100","unstructured":"Agyemang-Yeboah F. Oxidative stress and adipokines and their health implications. In: Pandalai S., editor. Topical Series in Health Science 1 (TSHS-1), Research Signpost; 2013."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib101","doi-asserted-by":"crossref","first-page":"461S","DOI":"10.1093\/ajcn\/83.2.461S","article-title":"Obesity and the role of adipose tissue in inflammation and metabolism","volume":"83","author":"Greenberg","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib102","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","article-title":"Fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk","volume":"23","author":"Stern","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib103","first-page":"905","article-title":"Association between expression of AMPK pathway and adiponectin, leptin, and vascular endothelial function in rats with coronary heart disease","volume":"24","author":"Li","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib104","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1111\/bph.13650","article-title":"The role of perivascular adipose tissue in obesity\u2010induced vascular dysfunction","volume":"174","author":"Xia","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fphys.2018.00341","article-title":"Increased O-GlcNAcylation of endothelial nitric oxide synthase compromises the anti-contractile properties of perivascular adipose tissue in metabolic syndrome","volume":"9","author":"da Costa","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib106","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.111.027375","article-title":"Role of perivascular adipose tissue\u2013derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension","volume":"124","author":"Lee","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib107","doi-asserted-by":"crossref","first-page":"122491","DOI":"10.1016\/j.lfs.2024.122491","article-title":"Role of hydrogen sulfide in the regulation of lipid metabolism: implications on cardiovascular health","volume":"341","author":"Lorenzo","year":"2024","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib108","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tcm.2010.12.002","article-title":"Omentin: a novel link between inflammation, diabesity, and cardiovascular disease","volume":"20","author":"Tan","year":"2010","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib109","series-title":"Omentin Activates AMP-activated Protein Kinase and Plays a Role in Energy Metabolism and Immune Response (PhD Dissertation)","author":"Yu","year":"2011"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120424_bib110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1042\/CS20120536","article-title":"Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation","volume":"124","author":"Bijland","year":"2013","journal-title":"Clin Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib111","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2011.04.039","article-title":"Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells","volume":"408","author":"Yamawaki","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib112","doi-asserted-by":"crossref","first-page":"113830","DOI":"10.1016\/j.bcp.2020.113830","article-title":"Omentin-1 protects against high glucose-induced endothelial dysfunction via the AMPK\/PPAR\u03b4 signaling pathway","volume":"174","author":"Liu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib113","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000506405","article-title":"Increased release of proinflammatory proteins in primary human adipocytes and activation of the inflammatory NF\u0138B, p38, and ERK pathways upon omentin treatment","volume":"13","author":"Niersmann","year":"2020","journal-title":"Obes Facts"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib114","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/j.2040-4603.2017.tb00769.x","article-title":"Adipose tissue-derived omentin-1 function and regulation","volume":"7","author":"Watanabe","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/VHRM.S33760","article-title":"The influence of perivascular adipose tissue on vascular homeostasis","volume":"9","author":"Szasz","year":"2013","journal-title":"Vasc Health Risk Manag"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120424_bib116","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1161\/ATVBAHA.114.303030","article-title":"Proinflammatory phenotype of perivascular adipocytes","volume":"34","author":"Omar","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib117","article-title":"Role of inflammation in vascular disease-related perivascular adipose tissue dysfunction","volume":"12","author":"Chen","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib118","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1\u03b1 during hypoxia","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib119","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/antiox12081595","article-title":"Perivascular adipose tissue oxidative stress in obesity","volume":"12","author":"Man","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib120","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1111\/bph.13687","article-title":"Increased mitochondrial ROS generation mediates the loss of the anti\u2010contractile effects of perivascular adipose tissue in high\u2010fat diet obese mice","volume":"174","author":"Costa","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib121","doi-asserted-by":"crossref","first-page":"2734321","DOI":"10.1155\/2022\/2734321","article-title":"Exploring the relationship of perivascular adipose tissue inflammation and the development of vascular pathologies","volume":"2022","author":"Rami","year":"2022","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib122","doi-asserted-by":"crossref","first-page":"1393343","DOI":"10.3389\/fnut.2024.1393343","article-title":"Exercise attenuates high-fat diet-induced PVAT dysfunction through improved inflammatory response and BMP4-regulated adipose tissue browning","volume":"11","author":"Liu","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib123","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1111\/bph.13685","article-title":"Anti\u2010atherosclerotic effect of the angiotensin 1\u20137 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis","volume":"174","author":"Skiba","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib124","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/ATVBAHA.108.165423","article-title":"A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice","volume":"28","author":"Braunersreuther","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib125","first-page":"253","article-title":"Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice, circulation research","volume":"94","author":"Veillard","year":"2004","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib126","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib127","first-page":"165","article-title":"Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target","author":"Aghamohammadzadeh","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib128","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100684RR","article-title":"Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes","volume":"35","author":"Ballasy","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.990155","article-title":"Fat-to-heart crosstalk in health and disease","volume":"14","author":"Lodewijks","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib130","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1113\/JP273049","article-title":"The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles","volume":"595","author":"Antonopoulos","year":"2017","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib131","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbadis.2016.07.019","article-title":"The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance","volume":"1863","author":"Ramalingam","year":"2017","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib132","first-page":"e58","article-title":"Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling, circulation research","volume":"90","author":"Mollnau","year":"2002","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib134","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","article-title":"NLRP3 inflammasome in endothelial dysfunction","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030629","article-title":"Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge","volume":"10","author":"Gutierrez-Cuevas","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib136","first-page":"2460","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators, circulation","volume":"108","author":"Mazurek","year":"2003","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib137","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.regpep.2010.07.169","article-title":"Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease","volume":"165","author":"Shibasaki","year":"2010","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib138","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.numecd.2015.12.005","article-title":"Epicardial adipocyte hypertrophy: association with M1-polarization and toll-like receptor pathways in coronary artery disease patients","volume":"26","author":"Vianello","year":"2016","journal-title":"Nutr Metabol Cardiovasc Dis : Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156119","article-title":"Human epicardial adipose tissue inflammation correlates with coronary artery disease","volume":"162","author":"Fan","year":"2023","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacc.2011.01.048","article-title":"Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue","volume":"58","author":"Hirata","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib141","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145495","article-title":"Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation","volume":"6","author":"Vyas","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib142","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/j.2040-4603.2017.tb00767.x","article-title":"Role of epicardial adipose tissue in health and disease: a matter of fat?","volume":"7","author":"Gaborit","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib143","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2796.2007.01825.x","article-title":"PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?","volume":"262","author":"Ahmed","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib144","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0003319711401012","article-title":"Peroxisome proliferator-activated receptors and atherosclerosis","volume":"62","author":"Soski\u0107","year":"2011","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/15209150260007381","article-title":"Physiological and therapeutic roles of peroxisome proliferator-activated receptors","volume":"4","author":"Berger","year":"2002","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib146","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"99","author":"Ahmadian","year":"2013","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib147","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-\u03b2\/\u03b4 and PPAR-\u03b3","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120424_bib148","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/1389450118666170622091333","article-title":"Advances on PPAR\u03b3 research in the emerging era of precision medicine","volume":"19","author":"Lu","year":"2018","journal-title":"Curr Drug Targets"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120424_bib149","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/156802612799436632","article-title":"Update on cardiovascular safety of PPARgamma agonists and relevance to medicinal chemistry and clinical pharmacology","volume":"12","author":"Ciudin","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","article-title":"Potential role of CYP1B1 in the development and treatment of metabolic diseases","volume":"178","author":"Li","year":"2017","journal-title":"Pharmacol Therapeut"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib151","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/jmf.2017.3916","article-title":"The therapeutic potential of piceatannol, a natural stilbene, in metabolic diseases: a review","volume":"20","author":"Kershaw","year":"2017","journal-title":"J Med Food"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib152","first-page":"75","article-title":"Emerging role of toll-like receptors in atherosclerosis, important aspects of toll-like receptors","author":"Hadi","year":"2021","journal-title":"Signal Path Dis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib153","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/acsptsci.9b00100","article-title":"The role of toll-like receptors in atherothrombotic cardiovascular disease","volume":"3","author":"Zhou","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib154","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2015.05.038","article-title":"The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis","volume":"241","author":"Hovland","year":"2015","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/0929867323666151207111408","article-title":"Essential roles of toll-like receptors in atherosclerosis","volume":"23","author":"Lin","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib156","first-page":"56","volume":"17","author":"Kytikova","year":"2020","journal-title":"Toll-like receptors in the pathophysiology of obesity"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib157","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"Jialal","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib158","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fendo.2012.00181","article-title":"Implication of inflammatory signaling pathways in obesity-induced insulin resistance","volume":"3","author":"Tanti","year":"2013","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib159","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","article-title":"Macrophages, immunity, and metabolic disease","volume":"41","author":"McNelis","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib160","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib161","doi-asserted-by":"crossref","first-page":"602088","DOI":"10.3389\/fcvm.2020.602088","article-title":"Adipose tissue immunomodulation: a novel therapeutic approach in cardiovascular and metabolic diseases","volume":"7","author":"AlZaim","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib162","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s42255-022-00671-0","article-title":"Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice","volume":"4","author":"Shi","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib163","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nm.3713","article-title":"The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuating hepatic lipogenesis","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib164","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2017.03.051","article-title":"Targeting white, brown and perivascular adipose tissue in atherosclerosis development","volume":"816","author":"van Dam","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib165","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1038\/s41467-022-32658-6","article-title":"Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling","volume":"13","author":"Adachi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib166","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/ATVBAHA.110.207175","article-title":"Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue","volume":"30","author":"Takaoka","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib167","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MOL.0000000000000522","article-title":"Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk","volume":"29","author":"Pich\u00e9","year":"2018","journal-title":"Curr Opin Lipidol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120424_bib168","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2013.06.027","article-title":"Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality","volume":"62","author":"Britton","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib169","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1194\/jlr.R086975","article-title":"Determinants of body fat distribution in humans may provide insight about obesity-related health risks","volume":"60","author":"Frank","year":"2018","journal-title":"JLR (J Lipid Res)"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib170","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.2337\/db14-1085","article-title":"A lifetime on the hips: programming lower-body fat to protect against metabolic disease","volume":"63","author":"Swarbrick","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib171","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12933-025-02596-w","article-title":"Obesity-induced mesenteric PVAT remodelling is sexually dimorphic, but not driven by ovarian hormones : short title: obesity induces sex-specific responses in mesenteric PVAT","volume":"24","author":"Ivatt","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib172","doi-asserted-by":"crossref","first-page":"H1065","DOI":"10.1152\/ajpheart.00180.2025","article-title":"Overexpression of adipose tissue ERalpha enhances PVAT anticontractility via NOX4-derived H(2)O(2) and is protective against high-fat diet-induced dysfunction","volume":"328","author":"Costa","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib173","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/ATVBAHA.107.147835","article-title":"Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis","volume":"27","author":"Gustafson","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib174","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","article-title":"Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes","volume":"496","author":"Reddy","year":"2019","journal-title":"Clin Chim Act Int J Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.707126","article-title":"Perirenal adipose tissue inflammation: novel insights linking metabolic dysfunction to renal diseases","volume":"12","author":"Hammoud","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib176","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1074\/jbc.M111.261818","article-title":"Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism","volume":"287","author":"Maruyama","year":"2011","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120424_bib177","doi-asserted-by":"crossref","first-page":"H1501","DOI":"10.1152\/ajpheart.00443.2015","article-title":"Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway","volume":"309","author":"Han","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib178","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2011.08.083","article-title":"Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase\/Akt pathway","volume":"413","author":"Jung","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib179","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1074\/jbc.M310389200","article-title":"Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells","volume":"279","author":"Ouchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib180","doi-asserted-by":"crossref","first-page":"1253433","DOI":"10.3389\/fimmu.2023.1253433","article-title":"Multi-faceted roles of C1q\/TNF-related proteins family in atherosclerosis","volume":"14","author":"Guo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib181","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/ATVBAHA.111.231050","article-title":"C1q\/TNF-Related proteins, A family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1\/AMPK\/eNOS\/nitric oxide signaling pathway","volume":"31","author":"Zheng","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib182","first-page":"482","article-title":"Vaspin alleviates dysfunction of endothelial progenitor cells induced by high glucose via PI3K\/Akt\/eNOS pathway","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib183","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12967-022-03542-0","article-title":"Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38\/Elk-1 pathway","volume":"20","author":"Zou","year":"2022","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib184","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120424_bib185","first-page":"849","article-title":"Sphingosine signaling and atherogenesis","volume":"25","author":"Xu","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib186","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/ph4010117","article-title":"Sphingosine-1-Phosphate-Specific G protein-coupled receptors as novel therapeutic targets for atherosclerosis","volume":"4","author":"Okamoto","year":"2011","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib187","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5551\/jat.RV17010","article-title":"Sphingosine 1-phosphate and atherosclerosis","volume":"25","author":"Kurano","year":"2018","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177588","article-title":"Omentin-1 attenuates atrial fibrillation via Src\/PI3K\/Akt signaling-mediated anti-fibrotic effects in cardiac fibroblasts","volume":"996","author":"Li","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101625","article-title":"Does adiponectin inform cardiovascular risk in older adults?: the ARIC study","volume":"4","author":"Abushamat","year":"2025","journal-title":"JACC Adv"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120424_bib190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1389450115666141109213439","article-title":"The role of adipocytokines in atherogenesis and atheroprogression","volume":"16","author":"Carbone","year":"2015","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib191","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4239\/wjd.v5.i3.357","article-title":"Adipokines as a novel link between obesity and atherosclerosis","volume":"5","author":"Yoo","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib192","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1161\/01.CIR.0000147825.97879.E7","article-title":"Resistin promotes smooth muscle cell proliferation through activation of extracellular signal\u2013regulated kinase 1\/2 and phosphatidylinositol 3-kinase pathways","volume":"110","author":"Calabr\u00f2","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib193","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.2011.01369.x","article-title":"Resistin: functional roles and therapeutic considerations for cardiovascular disease","volume":"165","author":"Jamaluddin","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib194","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00018-022-04401-3","article-title":"Contribution of specific ceramides to obesity-associated metabolic diseases","volume":"79","author":"Hammerschmidt","year":"2022","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib195","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib196","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.122.318048","article-title":"Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential","author":"Zietzer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib197","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/1535370214527903","article-title":"Perivascular adipose tissue-derived leptin promotes vascular smooth muscle cell phenotypic switching via p38 mitogen-activated protein kinase in metabolic syndrome rats","volume":"239","author":"Li","year":"2014","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib198","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.3390\/ijms22115446","article-title":"Leptin in atherosclerosis: focus on macrophages, endothelial and smooth muscle cells","volume":"22","author":"Raman","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib199","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007442","article-title":"Adipose\u2010derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization","volume":"7","author":"Xie","year":"2018","journal-title":"J Am Heart Assoc: Cardiovasc Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120424_bib200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/13816128113199990022","article-title":"Leptin and vascular smooth muscle cells","volume":"20","author":"Trovati","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib201","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1002\/jcp.30345","article-title":"Visfatin: an emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases","volume":"236","author":"Dakroub","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/ijtm1010004","article-title":"The contribution of endothelial-mesenchymal transition to atherosclerosis","volume":"1","author":"Zhang","year":"2021","journal-title":"Int J Translat Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fcvm.2020.00053","article-title":"Endothelial-to-Mesenchymal transition, vascular inflammation, and atherosclerosis","volume":"7","author":"Chen","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib204","doi-asserted-by":"crossref","first-page":"734550","DOI":"10.3389\/fcvm.2021.734550","article-title":"Endothelial to mesenchymal transition: an insight in atherosclerosis","volume":"8","author":"Huang","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120424_bib205","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1172\/JCI82719","article-title":"Endothelial-to-mesenchymal transition drives atherosclerosis progression","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib206","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cvr\/cvx253","article-title":"Endothelial\u2013mesenchymal transition in atherosclerosis","volume":"114","author":"Souilhol","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib207","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2011.12.014","article-title":"Adiponectin-AdipoR1\/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses","volume":"221","author":"Tian","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib208","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.atherosclerosis.2008.04.011","article-title":"Adiponectin reduces lipid accumulation in macrophage foam cells","volume":"202","author":"Tian","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2018.02.008","article-title":"The role of adiponectin and adipolin as anti-inflammatory adipokines in the formation of macrophage foam cells and their association with cardiovascular diseases","volume":"54","author":"Sargolzaei","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165305","article-title":"Chemerin stimulates vascular smooth muscle cell proliferation and carotid neointimal hyperplasia by activating mitogen-activated protein kinase signaling","volume":"11","author":"Xiong","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/abbs\/gmq025","article-title":"Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1\/2 and NF-kappaB","volume":"42","author":"Huang","year":"2010","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib212","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1582-4934.2010.01099.x","article-title":"Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells","volume":"15","author":"Lamers","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib213","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/13813455.2015.1045520","article-title":"Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression","volume":"121","author":"Schlich","year":"2015","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib214","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1476-5381.2011.01404.x","article-title":"The role of perivascular adipose tissue in vascular smooth muscle cell growth","volume":"165","author":"Miao","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib215","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/cells10061485","article-title":"Role of perivascular adipose tissue-derived adiponectin in vascular homeostasis","volume":"10","author":"Sowka","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib216","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/cvr\/cvz074","article-title":"Adipolin\/CTRP12 protects against pathological vascular remodeling through suppression of smooth muscle cell growth and macrophage inflammatory response","volume":"116","author":"Ogawa","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib217","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tcm.2024.03.003","article-title":"The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: an anti-atherosclerotic action","volume":"34","author":"Alexiadou","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib218","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/CIRCULATIONAHA.118.034516","article-title":"Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke: post hoc analysis from the LEADER trial","volume":"138","author":"Verma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib219","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/dc16-2736","article-title":"Cardiovascular disease and type 2 diabetes: has the dawn of a new era arrived?","volume":"40","author":"Abdul-Ghani","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib220","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1111\/dom.14140","article-title":"Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: results from the LEADER and SUSTAIN 6 clinical trials","volume":"22","author":"Verma","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib221","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/dom.13698","article-title":"Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: a post hoc analysis of the LEADER and SUSTAIN 6 clinical trials","volume":"21","author":"Verma","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib222","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s13300-020-00882-2","article-title":"Subpopulation differences in the cardiovascular efficacy of long-acting glucagon-like peptide 1 receptor agonists in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"He","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib223","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1573399812666151223093841","article-title":"Glucagon-like peptide-1 receptor agonists for type 2 diabetes: a clinical update of safety and efficacy","volume":"12","author":"Drab","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib224","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1586\/17446651.2015.1057502","article-title":"A systematic review of the safety of incretin-based therapies in type 2 diabetes","volume":"11","author":"Evans","year":"2016","journal-title":"Expet Rev Endocrinol Metabol"},{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2025.120424_bib225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud : Reg Dev Stud"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib226","first-page":"1233","article-title":"Safety issues with glucagon\u2010like peptide\u20101 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): data from randomized controlled trials","volume":"19","author":"Monami","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib227","article-title":"Safety of semaglutide","volume":"12","author":"Smits","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108255","article-title":"Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - a systematic review and meta-analysis","volume":"36","author":"Yoshida","year":"2022","journal-title":"J Diabet Complicat"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib229","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1097\/MS9.0000000000002712","article-title":"Unlocking the potential of glucagon-like peptide-1 receptor agonists in revolutionizing type 2 diabetes management: a comprehensive review","volume":"86","author":"Joshi","year":"2024","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib230","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamacardio.2020.1966","article-title":"Use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and cardiovascular disease: a review","volume":"5","author":"Honigberg","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib231","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review","volume":"16","author":"Hamed","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib232","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvae047","article-title":"SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits","volume":"120","author":"Preda","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib233","article-title":"Exploring the cardiovascular benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors: expanding horizons beyond diabetes management","volume":"15","author":"Fatima","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib234","first-page":"241","article-title":"Series: cardiovascular outcome trials for diabetes drugs Canagliflozin and the CANVAS Program, dapagliflozin and DECLARE-TIMI 58, ertugliflozin and VERTIS CV","volume":"21","author":"Fisher","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib235","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/eurjpc\/zwab034","article-title":"Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin","volume":"29","author":"Fontes-Carvalho","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib236","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/2047487318755531","article-title":"Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: a systematic review and meta-analysis","volume":"25","author":"Usman","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib237","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ehjcvp\/pvac001","article-title":"SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis","volume":"8","author":"Razuk","year":"2022","journal-title":"Eur Heart J Cardiovascul Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib238","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3390\/jcm12082824","article-title":"Pleiotropic effects of sodium-glucose cotransporter-2 inhibitors in cardiovascular disease and chronic kidney disease","volume":"12","author":"Rastogi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib239","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14740338.2019.1602116","article-title":"An update on the safety of SGLT2 inhibitors","volume":"18","author":"Scheen","year":"2019","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00592-018-1116-0","article-title":"SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Puckrin","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib241","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/M19-0085","article-title":"Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases","volume":"170","author":"Bersoff-Matcha","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib242","first-page":"34","article-title":"A safety update on sodium glucose co\u2010transporter 2 inhibitors","volume":"21","author":"Fitchett","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib243","first-page":"72","article-title":"SGLT2 inhibitors: are they safe?","volume":"130","author":"Filippas-Ntekouan","year":"2018","journal-title":"PGM (Postgrad Med)"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120424_bib244","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2174\/1381612823666170113152742","article-title":"Sodium-glucose cotransporter 2 inhibitors (SGLT2i): their role in cardiometabolic risk management","volume":"23","author":"Katsiki","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib245","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ndt\/gfac283","article-title":"Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease","volume":"38","author":"Nee","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib246","first-page":"35","article-title":"Key results from observational studies and real\u2010world evidence of sodium\u2010glucose cotransporter\u20102 inhibitor effectiveness and safety in reducing cardio\u2010renal risk","volume":"26","author":"Nystr\u00f6m","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib247","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/dom.14684","article-title":"Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: barriers and solutions for improving uptake in routine clinical practice","volume":"24","author":"Khunti","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib248","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12929-021-00720-y","article-title":"PPAR\u03b3 activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity","volume":"28","author":"Chen","year":"2021","journal-title":"J Biomed Sci"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib249","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.CIR.101.3.235","article-title":"Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators","volume":"101","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib250","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature11132","article-title":"PPAR\u03b3 is a major driver of the accumulation and phenotype of adipose-tissue Treg cells","volume":"486","author":"Cipolletta","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib251","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amjmed.2011.08.025","article-title":"The cardiovascular effects of peroxisome proliferator-activated receptor agonists","volume":"125","author":"Friedland","year":"2012","journal-title":"Am J Med"},{"issue":"49","key":"10.1016\/j.atherosclerosis.2025.120424_bib252","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1055\/s-2007-993110","article-title":"[Therapy with glitazones--a risk for cardiovascular disease?","volume":"132","author":"Rottlaender","year":"2007","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib253","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinternmed.2010.207","article-title":"Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality","volume":"170","author":"Nissen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib254","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/clc.20312","article-title":"Reassessing the cardiovascular risks and benefits of thiazolidinediones","volume":"31","author":"Zinn","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib255","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1111\/bph.13029","article-title":"The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges","volume":"172","author":"Cheang","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib256","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1874467211205020264","article-title":"Assessment of cardiac safety for PPAR\u03b3 agonists in rodent models of heart failure: a translational medicine perspective","volume":"5","author":"Wang","year":"2012","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib257","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1210\/me.2013-1427","article-title":"Minireview: challenges and opportunities in development of PPAR agonists","volume":"28","author":"Wright","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib258","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.3390\/ijms20205055","article-title":"Exploration and development of PPAR modulators in health and disease: an update of clinical evidence","volume":"20","author":"Cheng","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib259","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2217\/pgs-2019-0092","article-title":"Activation of HCAR2 by niacin: benefits beyond lipid lowering","volume":"20","author":"Tuteja","year":"2019","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOL.0b013e3283613a68","article-title":"Recent advances in niacin and lipid metabolism","volume":"24","author":"Kamanna","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib261","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MOL.0000000000000017","article-title":"Niacin: a long history, but a questionable future","volume":"24","author":"Ginsberg","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib262","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1093\/cvr\/cvz303","article-title":"Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+\/nicotinamide","volume":"116","author":"Horimatsu","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib263","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/15353702221084632","article-title":"Niacin promotes the efflux of lysosomal cholesterol from macrophages via the CD38\/NAADP signaling pathway","volume":"247","author":"Yang","year":"2022","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib264","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacl.2017.08.005","article-title":"Niacin and heart disease prevention: engraving its tombstone is a mistake","volume":"11","author":"Superko","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib265","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2016.07.038","article-title":"Role of niacin in current clinical practice: a systematic review","volume":"130","author":"Garg","year":"2017","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib266","doi-asserted-by":"crossref","first-page":"79","DOI":"10.23736\/S0026-4806.18.05826-3","article-title":"Role of niacin in current clinical practice","volume":"110","author":"Sharma","year":"2019","journal-title":"Minerva Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120424_bib267","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2012.10.030","article-title":"The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression","volume":"61","author":"Lavigne","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib268","first-page":"CD009744","article-title":"Niacin for primary and secondary prevention of cardiovascular events","volume":"6","author":"Schandelmaier","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib269","first-page":"342","article-title":"Trial of niacin alongside statin is stopped early","author":"Wise","year":"2011","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib270","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heartjnl-2011-301615","article-title":"Cardiovascular highlights from non-cardiology journals","volume":"98","author":"Lindsay","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib271","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.clinthera.2019.06.012","article-title":"Serious adverse effects of extended-release niacin\/laropiprant: results from the heart protection study 2-treatment of HDL to reduce the incidence of vascular events (HPS2-THRIVE) trial","volume":"41","author":"Haynes","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib272","first-page":"g4774","article-title":"Niacin fails to reduce vascular events in large randomised trial","volume":"349","author":"McCarthy","year":"2014","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib273","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3949\/ccjm.79a.11166","article-title":"Is niacin ineffective? Or did AIM-HIGH miss its target?","volume":"79","author":"Nicholls","year":"2012","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib274","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/1874192401307010090","article-title":"Niacin modulates pro-inflammatory cytokine secretion. A potential mechanism involved in its anti-atherosclerotic effect","volume":"7","author":"Lipszyc","year":"2013","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib275","doi-asserted-by":"crossref","first-page":"22C","DOI":"10.1016\/j.amjcard.2006.11.018","article-title":"Safety considerations with niacin therapy","volume":"99","author":"Guyton","year":"2007","journal-title":"Commentary, American Journal of Cardiology"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib276","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4065\/mcp.2009.0535","article-title":"A \"hot\" topic in dyslipidemia management--\"how to beat a flush\": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention","volume":"85","author":"Jacobson","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib277","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14740338.2012.682981","article-title":"Nicotinic acid: clinical considerations","volume":"11","author":"Kei","year":"2012","journal-title":"Expet Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120424_bib278","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"Mckenney","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib279","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jnutbio.2016.09.008","article-title":"Niacin and its metabolites as master regulators of macrophage activation","volume":"39","author":"Montserrat-de la Paz","year":"2017","journal-title":"The Journal of nutritional biochemistry"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071285","article-title":"Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice","volume":"8","author":"Wanders","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib281","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/nu12082427","article-title":"The absence of adiponectin alters niacin\u2019s effects on adipose tissue inflammation in mice","volume":"12","author":"Graff","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib282","article-title":"Assessment of the role of niacin in managing cardiovascular disease outcomes: a systematic review and meta-analysis","volume":"2","author":"D'Andrea","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib283","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1677\/JOE-07-0284","article-title":"Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue","volume":"197","author":"G\u00e1lvez-Prieto","year":"2008","journal-title":"J Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2025.120424_bib284","first-page":"S14","article-title":"Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy","volume":"8","author":"Giles","year":"2007","journal-title":"Rev Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib285","first-page":"45","article-title":"Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?","volume":"7","author":"Weber","year":"2006","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib286","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin-angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120424_bib287","first-page":"49","article-title":"Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials","volume":"45","author":"K\u0131z\u0131l\u0131rmak","year":"2017","journal-title":"Turk Kardiyol Dernegi Arsivi : Turk Kardiyoloji Derneginin yayin organidir"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120424_bib288","first-page":"SR23","article-title":"Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?","volume":"10","author":"Boos","year":"2004","journal-title":"Med Sci Monit : Int Med J Exper Clin Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib289","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pcad.2015.11.004","article-title":"The divergent cardiovascular effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on myocardial infarction and death","volume":"58","author":"Strauss","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1751-7141.2008.08435.x","article-title":"Use of angiotensin-converting enzyme inhibitor\/angiotensin II receptor blocker therapy to reduce cardiovascular events in high-risk patients: Part 1","volume":"11","author":"Bommer","year":"2008","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib291","doi-asserted-by":"crossref","first-page":"752406","DOI":"10.1155\/2009\/752406","article-title":"The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies","volume":"2009","author":"Montecucco","year":"2009","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib292","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1042\/CS20201099","article-title":"Renin-angiotensin system overactivation in perivascular adipose tissue contributes to vascular dysfunction in heart failure","volume":"134","author":"Fontes","year":"2020","journal-title":"Clin Sci"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120424_bib293","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/j.2040-4603.2017.tb00776.x","article-title":"Regulation and functions of the renin-angiotensin system in white and Brown adipose tissue","volume":"7","author":"Pahlavani","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib294","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.117.09512","article-title":"Perivascular adipose tissue angiotensin II type 1 receptor promotes vascular inflammation and aneurysm formation","volume":"70","author":"Sakaue","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib295","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jvs.2018.09.064","article-title":"Perivascular adipose tissue modulates carotid plaque formation induced by disturbed flow in mice","volume":"70","author":"Ren","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib296","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1470320314552434","article-title":"Transplantation of periaortic adipose tissue from angiotensin receptor blocker-treated mice markedly ameliorates atherosclerosis development in apoE\u2013\/\u2013 mice","volume":"16","author":"Irie","year":"2015","journal-title":"J Renin-Angiotensin-Aldosterone Syst JRAAS"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120424_bib297","first-page":"770","article-title":"Renin-angiotensin system and atherosclerosis, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association","volume":"19","author":"Grote","year":"2004","journal-title":"Eur Renal Assoc"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib298","first-page":"984","article-title":"Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice","volume":"118","author":"Lu","year":"2008","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib299","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/ncomms7356","article-title":"Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development","volume":"6","author":"Berb\u00e9e","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib300","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1038\/ncomms15010","article-title":"Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport","volume":"8","author":"Bartelt","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib301","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fendo.2012.00015","article-title":"Assessment of oxidative metabolism in brown fat using PET imaging","volume":"3","author":"Muzik","year":"2012","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib302","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/db12-1430","article-title":"Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes","volume":"62","author":"Sacks","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib303","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41366-018-0104-3","article-title":"Kinetics of human Brown adipose tissue activation and deactivation","volume":"43","author":"Leitner","year":"2018","journal-title":"Int J Obes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib304","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/er.2012-1081","article-title":"Brown adipose tissue in adult humans: a metabolic renaissance","volume":"34","author":"Lee","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib305","first-page":"1","article-title":"Brown adipose tissue and aging","volume":"14","author":"Lecoultre","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib306","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/nu11020463","article-title":"Effects of pharmacological thermogenic adipocyte activation on metabolism and atherosclerotic plaque regression","volume":"11","author":"Worthmann","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120424_bib307","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1042\/CS20170276","article-title":"Recent advances in the detection of brown adipose tissue in adult humans: a review","volume":"132","author":"Ong","year":"2018","journal-title":"Clin Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib308","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1037458","article-title":"Interventions associated with brown adipose tissue activation and the impact on energy expenditure and weight loss: a systematic review","volume":"13","author":"Perez","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib309","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehad484","article-title":"Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers","volume":"44","author":"Antoniades","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib310","article-title":"Epicardial adipose tissue: a precise biomarker for cardiovascular risk, metabolic diseases, and target for therapeutic interventions","author":"Bogda\u0144ski","year":"2024","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib311","first-page":"1096","article-title":"SGLT2 inhibitors reduce epicardial adipose tissue more than GLP\u20101 agonists or exercise interventions in patients with type 2 diabetes mellitus and\/or obesity: a systematic review and network meta\u2010analysis","volume":"27","author":"Bao","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib312","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.3315","article-title":"The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis","author":"Theofilis","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib313","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076838","article-title":"The different pathways of epicardial adipose tissue across the heart failure phenotypes: from pathophysiology to therapeutic target","volume":"24","author":"Rossi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib314","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2337\/dbi20-0002","article-title":"Precision medicine in type 2 diabetes: using individualized prediction models to optimize selection of treatment","volume":"69","author":"Dennis","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib315","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/946427","article-title":"Visfatin\/Nampt: an adipokine with cardiovascular impact","volume":"2013","author":"Romacho","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib316","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.2527","article-title":"Epicardial adipose tissue volume improves cardiovascular risk reclassification: the Framingham Risk Score example","volume":"42","author":"Sousa","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib317","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/cvr\/cvz321","article-title":"Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study","volume":"116","author":"Commandeur","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib318","first-page":"101188","article-title":"AI prediction of cardiovascular events using opportunistic epicardial adipose tissue assessments from CT calcium score","volume":"3","author":"Hu","year":"2024","journal-title":"ArXiv"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib319","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/db20-0884","article-title":"Emerging role of bone morphogenetic protein 4 in metabolic disorders","volume":"70","author":"Baboota","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib320","doi-asserted-by":"crossref","first-page":"101979","DOI":"10.1016\/j.redox.2021.101979","article-title":"BMP4-mediated browning of perivascular adipose tissue governs an anti-inflammatory program and prevents atherosclerosis","volume":"43","author":"Mu","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib321","first-page":"E798","article-title":"BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis","volume":"110","author":"Qian","year":"2013"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib322","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/21623945.2017.1287637","article-title":"The dual role of BMP4 in adipogenesis and metabolism","volume":"6","author":"Modica","year":"2017","journal-title":"Adipocyte"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib323","doi-asserted-by":"crossref","first-page":"A9","DOI":"10.1210\/jendso\/bvab048.017","article-title":"Effects of colchicine on measures of lipolysis in adults with obesity","volume":"5","author":"Sarrafan-Chaharsoughi","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib324","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41366-020-0598-3","article-title":"Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial","volume":"44","author":"Demidowich","year":"2020","journal-title":"Int J Obes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib325","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/s41401-021-00835-w","article-title":"Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib326","first-page":"74","article-title":"The beneficial therapy with colchicine for atherosclerosis via anti-inflammation and decrease in hypertriglyceridemia, cardiovascular & hematological agents in medicinal chemistry","volume":"16","author":"Spartalis","year":"2019"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib327","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL 3-METTL 14 complex mediates mammalian nuclear RNA N 6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib328","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18434","article-title":"Structural insights into the molecular mechanism of the m6A writer complex","volume":"5","author":"\u015aled\u017a","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib329","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41467-024-55694-w","article-title":"Divergent roles of m6A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism","volume":"16","author":"Xiao","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib330","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301645","article-title":"Adipose METTL14\u2010elicited N6\u2010methyladenosine promotes obesity, insulin resistance, and NAFLD through suppressing \u03b2 adrenergic signaling and lipolysis","volume":"10","author":"Kang","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib331","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/cells11071101","article-title":"Emerging roles and mechanism of m6A methylation in cardiometabolic diseases","volume":"11","author":"Xu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib332","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.7150\/thno.45178","article-title":"METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications","volume":"10","author":"Jian","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib333","first-page":"440","article-title":"Medical imaging in the assessment of cardiovascular disease risk","volume":"26","author":"Alcantara","year":"2023","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib334","first-page":"416","article-title":"Epicardial adipose tissue: far more than a fat depot","volume":"4","author":"Talman","year":"2014","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/CRD.0000000000000153","article-title":"Epicardial fat: pathophysiology and clinical significance","volume":"25","author":"Douglass","year":"2017","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib336","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2025.120424_bib337","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1039\/C8AN01307A","article-title":"Raman spectroscopy as a novel tool for fast characterization of the chemical composition of perivascular adipose tissue","volume":"143","author":"Czamara","year":"2018","journal-title":"Analyst"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib338","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.carj.2013.05.003","article-title":"Vascular and Interventional Radiology \/ Radiologie vasculaire et radiologie d\u2019intervention Vulnerable Atherosclerotic Carotid Plaque Evaluation by Ultrasound, Computed Tomography Angiography. and Magnetic Resonance Imaging: An Overview","volume":"65","author":"Naim","year":"2014","journal-title":"Canadian Assoc. Radiol. J."},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib339","article-title":"The role of perivascular adipose tissue in microvascular function and coronary atherosclerosis","author":"Antonopoulos","year":"2019","journal-title":"Microcirculation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120424_bib340","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","article-title":"Adipokines in health and disease","volume":"36","author":"Fasshauer","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib341","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1373\/clinchem.2017.275172","article-title":"Addressing the perfect storm: biomarkers in obesity and pathophysiology of cardiometabolic risk","volume":"64","author":"Aleksandrova","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib342","first-page":"1","article-title":"Biomarkers of dysfunctional visceral fat","volume":"109","author":"Gugliucci","year":"2022","journal-title":"Adv Clin Chem"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120424_bib343","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2174\/15701611113116660170","article-title":"Adipobiology for novel therapeutic approaches in metabolic syndrome","volume":"11","author":"Malag\u00f3n","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib344","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cytogfr.2019.06.002","article-title":"The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus","volume":"48","author":"Liang","year":"2019","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib345","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3253096","article-title":"Using adipose measures from health care provider-based imaging data for discovery","volume":"2018","author":"Cha","year":"2018","journal-title":"J Obes"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib346","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1259\/bjr\/38447238","article-title":"The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis","volume":"85","author":"Shuster","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib347","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12933-023-02075-0","article-title":"Isthmin-1 (ISM1), a novel adipokine that reflects abdominal adipose tissue distribution in individuals with obesity","volume":"22","author":"Lopez-Yus","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib348","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.soard.2024.01.009","article-title":"Risk stratification using magnetic resonance imaging-derived, personalized z-scores of visceral adipose tissue, subcutaneous adipose tissue, and liver fat in persons with obesity","volume":"20","author":"Linge","year":"2024","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120424_bib349","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib350","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib351","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/1c88ae20-07d1-4fda-8cd8-058d95af057d","article-title":"Topographical body fat distribution links to amino acid and lipid metabolism in healthy obese women [corrected]","volume":"8","author":"Martin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib352","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000471488","article-title":"The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function","volume":"10","author":"Goossens","year":"2017","journal-title":"Obes Facts"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib353","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1210\/jc.2012-3673","article-title":"Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome","volume":"98","author":"Jialal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib354","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.numecd.2022.11.023","article-title":"Role of adipokines (omentin and visfatin) in coronary artery disease","volume":"33","author":"Ali","year":"2023","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MOL.0000000000000602","article-title":"Senescent cells in the development of cardiometabolic disease","volume":"30","author":"Postmus","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib356","doi-asserted-by":"crossref","first-page":"101601","DOI":"10.1016\/j.molmet.2022.101601","article-title":"Targeting cellular senescence in metabolic disease","volume":"66","author":"Palmer","year":"2022","journal-title":"Mol Metabol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib357","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/CS20190966","article-title":"The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders","volume":"134","author":"Liu","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib358","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12950","article-title":"Targeting senescent cells alleviates obesity\u2010induced metabolic dysfunction","volume":"18","author":"Palmer","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib359","doi-asserted-by":"crossref","first-page":"11676","DOI":"10.3390\/ijms241411676","article-title":"Physiological approaches targeting cellular and mitochondrial pathways underlying adipose organ senescence","volume":"24","author":"de Lange","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beem.2013.02.005","article-title":"Adipose tissue dysfunction contributes to obesity related metabolic diseases","volume":"27","author":"Bl\u00fcher","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib361","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12979-023-00378-0","article-title":"Obesity drives adipose-derived stem cells into a senescent and dysfunctional phenotype associated with P38MAPK\/NF-KB axis","volume":"20","author":"Grun","year":"2023","journal-title":"Immun Ageing"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib362","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.3390\/cells11203324","article-title":"Paracrine senescence of mesenchymal stromal cells involves inflammatory cytokines and the NF-kappaB pathway","volume":"11","author":"Chou","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib363","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","article-title":"Mitochondrial dysfunction induces senescence with a distinct secretory phenotype","volume":"23","author":"Wiley","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib364","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1101\/gad.343129.120","article-title":"Senescence and the SASP: many therapeutic avenues","volume":"34","author":"Birch","year":"2020","journal-title":"Genes Dev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib365","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s13287-021-02509-0","article-title":"Age-related alteration in characteristics, function, and transcription features of ADSCs","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120424_bib366","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/rej.2009.0830","article-title":"A comprehensive review on mesenchymal stem cell growth and senescence","volume":"12","author":"Ksi\u0105\u017cek","year":"2009","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib367","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13015","article-title":"Aging induces cardiac mesenchymal stromal cell senescence and promotes endothelial cell fate of the CD90 + subset","volume":"18","author":"Martini","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib368","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/jcm8060765","article-title":"Adipose-derived mesenchymal stem cells isolated from patients with type 2 diabetes show reduced \u201cstemness\u201d through an altered secretome profile, impaired anti-oxidative protection, and mitochondrial dynamics deterioration","volume":"8","author":"Alicka","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib369","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1634\/stemcells.2008-0261","article-title":"IFATS collection: fibroblast growth factor-2-induced hepatocyte growth factor secretion by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism","volume":"27","author":"Suga","year":"2009","journal-title":"Stem Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/gerona\/glt043","article-title":"Adipogenic differentiation is impaired in replicative senescent human subcutaneous adipose-derived stromal\/progenitor cells","volume":"69","author":"Mitterberger","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib371","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12950","article-title":"Targeting senescent cells alleviates obesity-induced metabolic dysfunction","volume":"18","author":"Palmer","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib372","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.mad.2012.03.014","article-title":"Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: implication to age-associated bone diseases and defects","volume":"133","author":"Kim","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib373","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mad.2004.11.014","article-title":"Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells","volume":"126","author":"Park","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib374","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12997","article-title":"Targeting senescent cells enhances adipogenesis and metabolic function in old age","volume":"4","author":"Xu","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib375","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.3390\/ijms24087468","article-title":"Gene therapy based on mesenchymal stem cells derived from adipose tissue for the treatment of obesity and its metabolic complications","volume":"24","author":"L\u00f3pez-Yus","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib376","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4252\/wjsc.v6.i3.312","article-title":"Adipose-derived stem cells: implications in tissue regeneration","volume":"6","author":"Tsuji","year":"2014","journal-title":"World J Stem Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib377","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.exger.2016.02.013","article-title":"Aging and adipose tissue: potential interventions for diabetes and regenerative medicine","volume":"86","author":"Palmer","year":"2016","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib378","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108765","article-title":"Adipose-derived stem cells: sources, potency, and implications for regenerative therapies","volume":"114","author":"Si","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib379","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1038\/s41467-021-27190-y","article-title":"CRISPR-enhanced human adipocyte \u201cbrowning\u201d as cell therapy for metabolic disease","volume":"12","author":"Tsagkaraki","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib380","doi-asserted-by":"crossref","first-page":"10565","DOI":"10.1038\/s41598-020-67293-y","article-title":"Proof-of-concept for CRISPR\/Cas9 gene editing in human preadipocytes: deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism","volume":"10","author":"Kamble","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib381","doi-asserted-by":"crossref","first-page":"1033501","DOI":"10.3389\/fcell.2022.1033501","article-title":"Pleiotropic effects of Syntaxin16 identified by gene editing in cultured adipocytes","volume":"10","author":"Bremner","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib382","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1101\/gr.246900.118","article-title":"Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance","volume":"29","author":"Chung","year":"2019","journal-title":"Genome Res"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120424_bib383","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2015.087","article-title":"Adenovirus-mediated somatic genome editing of pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-specific immune responses","volume":"26","author":"Wang","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib384","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20220003","article-title":"On the immunometabolic role of NF-\u03baB in adipocytes","volume":"4","author":"Griffin","year":"2022","journal-title":"Immunometabolism"},{"issue":"15\u201316","key":"10.1016\/j.atherosclerosis.2025.120424_bib385","first-page":"738","article-title":"\u2217 CRISPR-based epigenome editing of cytokine receptors for the promotion of cell survival and tissue deposition in inflammatory environments, tissue engineering","volume":"23","author":"Farhang","year":"2017","journal-title":"Part A"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib386","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13767","article-title":"Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age","volume":"22","author":"Islam","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib388","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib389","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120424_bib390","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cmet.2008.08.017","article-title":"Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation","volume":"8","author":"Feige","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib391","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/MCB.00705-08","article-title":"SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes","volume":"29","author":"Yoshizaki","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120424_bib392","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","article-title":"Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle","volume":"11","author":"Cant\u00f3","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib393","first-page":"821","article-title":"Senolytics and senostatics: a two-pronged approach to target cellular senescence for delaying aging and age-related diseases","volume":"42","author":"Kang","year":"2019","journal-title":"Mol Cells"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib394","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.28","article-title":"Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells","volume":"46","author":"Han","year":"2014","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib395","first-page":"8270","article-title":"Combining stem cell rejuvenation and senescence targeting to synergistically extend lifespan","volume":"14","author":"Kaur","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib396","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13807","article-title":"Leptin is a potential biomarker of childhood obesity and an indicator of the effectiveness of weight-loss interventions","volume":"25","author":"Al Zein","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib397","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70371","article-title":"Metrnl and cardiomyopathies: from molecular mechanisms to therapeutic insights","volume":"29","author":"Xu","year":"2025","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.atherosclerosis.2025.120424_bib398","doi-asserted-by":"crossref","first-page":"H1204","DOI":"10.1152\/ajpheart.00093.2025","article-title":"PVAT adipocyte: energizing, modulating, and structuring vascular function during normotensive and hypertensive states","volume":"328","author":"Rendon","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502501322X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502501322X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:33:28Z","timestamp":1777192408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502501322X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":395,"alternative-id":["S002191502501322X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120424","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the secrets: Adipose tissue dysfunction and atherosclerosis-mechanisms and innovative therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120424"}}